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For several years, our group has been studying the in vivo role of adrenergic and cholinergic
mechanisms in the immune-neuroendocrine dialogue in the rat model. The main results of these
studies can be summarized as follows: (1) exogenous or endogenous catecholamines suppress
PBL functions through alpha-2-receptor-mediated mechanisms, lymphocytes of the spleen are
resistant to adrenergic in vivo stimulation, (2) direct or indirect cholinergic treatment leads to
enhanced ex vivo functions of splenic and thymic lymphocytes leaving PBL unaffected, (3)
cholinergic pathways play a critical role in the "talking back" of the immune system to the brain,
(4) acetylcholine inhibits apoptosis of thymocytes possibly via direct effects on thymic epithelial
cells, and may thereby influence T-cell maturation, (5) lymphocytes of the various
immunological compartments were found to be equipped with the key enzymes for the synthesis
of both acetylcholine and norepinephrine, and to secrete these neurotransmitters in culture
supernatants
Keywords: Neuroimmunomodulation, catecholamines, acetylcholine, lymphocytes, thymic epithelial cells,
apoptosis, choline-acetyl transferase, dopamine-beta-hydroxylase
INTRODUCTION
Investigations in the past decades have unraveled
close mutual relationships between the neuroendo-
crine and the immune systems (Cotman et al., 1987;
Chelmicka-Schorr and Arnason, 1990). Central and
peripheral lymphoid organs are innervated by the
sympathetic and parasympathetic systems with nerve
*Corresponding author.
terminals forming "synapsislike" contacts to the
immune cells (Bulloch and Moore, 1981; Felten et al.,
1987). Inversely, T lymphocytes were found to
regularly invade the central nervous system at random
(Hickey et al., 1991). A great variety of common
receptors, surface proteins, and mediators are
expressed at high levels in both the neuroendocrine
and the immune systems providing information
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exchange within as well as between the systems.
Adrenergic, muscarinic, and nicotinic cholinergic,
and many peptidergic receptors have been identified
on lymphocytes (Plaut, 1987). Activation of these
receptors can exert immunosuppressive or enhancing
effects, depending on the respective signal molecule,
the type of immune cell concerned (Blalock, 1989),
and the different microenvironments of lymphoid
tissues (Felsner et al., 1992; Rinner and Schauenstein,
1991; Rinner et al., 1992). The generation of neu-
rohormones, neuropeptides, and neurotransmitters by
thymocytes and peripheral lymphocytes has been
documented in several species (Smith et al., 1990;
Rinner and Schauenstein, 1993), and, on the other
hand, neural and endocrine tissues are known to
express lymphokines and monokines as well as high
densities of their membrane receptors (Velasco et al.,
1991; Cunningham and Souza, 1993). Functionally,
cytokines influence endocrine and central nervous
functions, including activation of the hypothalamic-
pituitary adrenal and hypothalamic-godanal axes,
induction of fever or slow wave sleep, and signaling
to the structures of the "limbic system" (Haas and
Schauenstein, 1997).
Our group is interested in defining the role of the
autonomous nervous system within the dialogue
between the central nervous system and the immune
system. In the rat model, we could show that the in
vivo treatment with adrenergic and cholinergic agon-
ists had pronounced and partly opposite effects on ex
vivo functions of lymphocytes (Rinner and Schauen-
stein, 1991; Felsner et al., 1992, 1995), and that the
cholinergic system particularly takes part in the
signaling from the peripheral immune system to the
brain (Rinner and Schauenstein, 1991).
ALPHA-ADRENERGIC SUPPRESSION OF
PBL PROLIFERATIVE RESPONSE IN THE
RAT MODEL
The literature data on adrenergic immunoregulation
are conflicting; both suppression and enhancement
have been reported as a consequence of alpha- or
beta-adrenergic stimulation (Hadden et al., 1970;
Pearlman, 1971; De Pelchin and Letesson, 1981;
Felten et al., 1987; Felten and Felten, 1994; Madden
et al., 1995). These differences are probably due to
differences in the experimental approach, such as, for
example, in vivo versus in vitro studies, species
differences, and epiphenomena due to "handling
stress" of laboratory animals (Rinner et. al., 1992).
In our own studies, we tried to define the in vivo
effects of chronically enhanced levels of peripheral
catecholamines on ex vivo functions of lymphocytes
of rats. The experimental model consists of s.c.
implantation of retard tablets that provide a controlled
release of adrenergic agonists or antagonists during
24 hr. The results obtained so far are summarized as
follows (Figure 1): 24 hr of administration of
adrenaline (or noradrenaline) did not or only margin-
ally change the proliferative response of peripheral
blood lymphocytes (PBL) to Concanavalin A (Con
A). Concomitant administration of the beta-receptor
blocker propranolol, but not of an alpha blocker,
caused a pronounced and significant decrease of the
mitogenic response ofPBL (Felsner et al., 1992). This
inhibition was shown to be mediated via alpha-
2-adrenergic receptors and it could be likewise
induced by administration of an indirect sympathomi-
metic drug (tyramine) in combination with beta
blockade (Felsner et al., 1995). The adrenergic
immunosuppression was not due to general stress
phenomena mediated by glucocorticoids, or shifts in
total T cells (CD3+) or T-cell subsets (CD4+CD8+).
Surprisingly, in our hands, this effect was strictly
confined to PBL; spleen cells were consistently
resistant to direct or indirect adrenergic treatment,
even though this organ is known to be strongly
innervated with sympathetic terminals. A similar
divergent sensitivity of spleen cells and PBL was
previously observed during immobilization stress,
which induced strong inhibition of the mitogenic
response of PBL, but increased the reactivity of
splenic cells (Rinner et al., 1992). It is possible that
adrenergic receptors of splenic lymphocytes, which
are in close contact to adrenergic fibers, are desensi-
tized due to high basal catecholamine levels.ADRENERGIC/CHOLINERGIC IMMUNOMODULATION 247
E
0
C A Pro A+Pro Phe A+Phe
FIGURE Concanavalin A response of peripheral blood lymphocytes of rats in whole-blood stimulation. In vivo treatment for 24 hr with
constant release of pellets containing placebo (C); adrenaline (A); 1.31 _+ 0.04 #g/min propranolol (Pro); 3.13 0.31 #g/min of adrenaline
+ propranolol (A + Pro); phentolamine (Phe); and 1.32 +_ 0.02 g/min of adrenaline + phentolamine (A + Phe). Rats were implanted
subcutaneously with retard tablets containing adrenaline, either alone or in combination with a blocker containing a retard tablet. Placebo
tablets consisted of the tablet matrix without a drug. After 24 hr, the animals were killed, blood was collected, and the spleens were excised.
Mitogen stimulation was determined in the whole blood and in spleen-cell suspensions after 3 days. Data represent the means _+ SEM of
maximal 3HTdR uptake related to the lymphocyte number in culture (CPM/lymphocyte). N 6 for each group.*** p < 0.01 significantly
different from controls according to Student’s t-test.
Our in vivo results are in contrast to reports of beta-
adrenoceptor-mediated immunosuppression by cate-
cholamines in vitro (Plaut, 1987) and in vivo (Chel-
micka-Schorr et al., 1993). They also suggest that,
besides enhanced catecholamine blood levels, adrene-
nergic immunosuppression requires a bias in the
alpha/beta adrenergic receptor balance. Recently, we
obtained evidence that endogenous melatonin confers
a strong protection to lymphocytes against the
suppressive effect of alpha-adrenergic stress. Beta-
adrenergic blockers inhibit the pineal release of
melatonin, and by virtue of this enforce the sup-
pressive effects of catecholamines (Liebmann et al.,
1996).
CHOLINERGIC ENHANCEMENT OF EX
VIVO FUNCTIONS OF SPLENIC AND
THYMIC LYMPHOCYTES
Since lymphocytes express muscarinic and nicotinic
cholinergic receptors and the developing T cells in the
thymus are not only in contact with the sympathetic,
but also with the parasympathetic cholinergic system,
we tested the effects of cholinergic treatment on
lymphocyte functions. Sprague Dawley rats were
implanted s.c. with retard tablets continuously releas-
ing the muscarinic cholinergic blocker atropine or the
inhibitor of acetylcholine esterase physostigmine.
After 5 days, the animals were sacrificed and the ex248 I. RINNER et al.
vivo Con A response of lymphocytes was determined.
Figure 2 shows the effects for PBL, and splenic and
thymic lymphocytes. Whereas PBL are unaffected by
any treatment, the mitogenic stimulation of spleen
cells is strongly suppressed by muscarinic receptor
blockade, and the response of thymocytes is signifi-
cantly increased by inhibition of acetylcholine degra-
dation by physostigmine. As with the adrenergic
effects, we are not able to explain the selective effects
of atropine and physostigmine on cells from different
immunological compartments. Further studies are
needed to solve this puzzle.
CHOLINERGIC PATHWAYS ARE
INVOLVED IN AFFERENT SIGNALING OF
THE IMMUNE SYSTEM TO THE BRAIN
Besedovsky et al. (1975) were first to describe a
regulatory feedback loop between the immune system
and the central nervous system. Cytokines released
from activated immune cells stimulate via specific
receptors the hypothalamic-pituitary-adrenal axis
leading to a transient increase in glucocorticoids in
the blood. This mechanism seems to be important for
the control of "forbidden clones," as defects in this
immuno-neuroendocrine feedback were shown in
several species to be associated with spontaneous or
experimentally induced autoimmune diseases
(Schauenstein et al., 1987; Sternberg et al., 1990). We
investigated the effect of the chronic administration of
physostigmine and/or atropine on the corticosterone
response in rats 4 days after i.p. immunization with
sheep red blood cells (Figure 3). Physostigmine
abrogated the rise in corticosterone; atropine had no
effect, but antagonized the suppression induced by
physostigmine. These data provided first evidence
that cholinergic mechanisms are involved in the
feedback regulation between the immune system and
brain. Further studies are presently underway to
determine if and to what degree alterations in the
endogenous cholinergic tonus may predispose an
animal to autoimmune reactions.
Z
0
0
300-
200-
100.
SRBC+A SRBC SRBC+P SRBC+A+B
FIGURE 2 Effect of 5 days’ treatment with constant release pellets containing placebo, atropine (1.2 mg/day), or physostigmine (0.012
mg/day) on concanavalin-A-stimulated 3H-TdR uptake of lymphocytes from the peripheral blood (WBS, whole-blood stimulation), the
spleen, and the thymus. Rats were implanted subcutaneously with retard tablets containing atropine or physostigmine. Placebo tablets
consisted of the tablet matrix without a drug. After 5 days, the animals were killed, blood was collected, and the spleens and thymuses were
excised. Mitogen stimulation was determined in the whole blood and in spleen- and thymus-cell suspensions after 3 days. ;Each group
represents the mean _+ SEM of seven rats. Significance of the difference from placebo-treated animals: p < 0.05 to Student’s t-test.ADRENERGIC/CHOLINERGIC IMMUNOMODULATION 249
ACETYLCHOLINE INHIBITS APOPTOSIS OF
THYMOCYTES VIA A DIRECT EFFECT ON
THYMIC EPITHELIUM AND MAY THEREBY
INFLUENCE T-CELL MATURATION
During T-cell maturation, nonreactive and autor-
eactive thymocytes are not positively selected or
eliminated by negative selection. The nonselected and
the negatively selected cells die by the induction of
apoptosis, the programmed cell death. This selection
is primarily based on cellular interactions between the
developing cells and the thymic epithelium, but
soluble factors produced by the epithelial cells can
modulate this process. In a coculture system, consist-
ing of nontransformed thymic epithelial cell (TEC)
lines (Hirokawa et al., 1986) and fetal thymic lobes,
we investigated the effect of this coculture on
thymocyte apoptosis and development (Rinner et al.,
1994, 1996). Coculture of fetal thymic lobes with a
cortical (TEC 1.4) and a medullary (TEC 2.3) TEC
line induced a decrease in cell number and an increase
of apoptotic cells in the thymus lobes (Table I), which
was significant with cortical TEC 1.4 cells only. This
effect was found to be restricted to thymic lympho-
cytes, and to be mediated by a > 30-kD factor in the
supernatant of TEC lines. Addition of the cholinergic
drug carbachol attenuated the apoptosis induction by
TEC 1.4 cells, but did not influence the apoptosis in
lobes without TECs, nor in presence of the medullary
TEC 2.3 line, suggesting that the primary targets of
the cholinergic effect are indeed the cells of the
cortical epithelial cell line. The attenuation could be
antagonized by d-tubocurarine, a nicotinic receptor
blocking agent (not shown). Coculture of thymic
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FIGURE 3 Effect of chronic cholinergic stimulation by physostigmine administration on corticosterone elevation 4 days after
immunization with sheep red blood cells. Control: no immunization; SRBC: 10 sheep red blood cells i.p.; SRBC+A: administration of
atropine (3 mg/kg) on the day of immunization and the following day; SRBC+P: administration of physostigmine (0.3 mg/kg) on the day
of immunization and the following day; SRBC+A+P: administration of physostigmine and atropine on the day of immunization and the
following day. The animals were killed, corticosterone was extracted from the diluted plasma, and the concentration of corticosterone was
determined by RIA. Each group represents the means SEM of eight rats. Statistical difference was determined using ANOVA, followed
by Dunnet’s t-test.250 I. RINNER et al.
TABLE Effect of In Vitro Treatment with Carbachol on the Percentage of Apoptotic Cells in Murine Fetal Thymus Cocultured with
Cortical (TEC 1.4) of Medullary (TEC 2.3) Epithelial Cells
No TEC TEC 1.4 TEC 2.3
Control 100.0 _+ 1.8 307.3 +_ 1.2 165.5 19.4
10-SM carbachol 95.8 16.4 257.6 28.4 112.1 26.1
10 M carbachol 101.2 14.5 207.9 9.1 a’b 105.5 24.8
10 M carbachol 115.2 _+ 10.3 267.3 12.2 98.2 12.1
Tec cells were seeded on Nucleopore filters resting on gelatine sponges. Fetal thymus lobes (day 15 after gestation) were placed on top of
each layer or control sponges without TEC. The cocultures were daily treated with the respective drug. Data are presented as percentage of
controls. Results are means +_ SEM of three independent experiments.Significantly different (p < 0.01) from the respective control without
drug.
bSignificantly different (p < 0.01) from cultures without TEC according to ANOVA and Student-Newaman-Keuls post hoc analysis.
Significantly different (p < 0.001) from cultures without TEC according to ANOVA and Student-Newaman-Keuls post hoc analysis.
lobes with TEC 1.4, but not with TEC 2.3, also
decreased the percentage of CD4/CD8 double-posi-
tive cells and increased the percentage of CD4/CD8
double-negative cells (not shown). Taken together,
these data indicate that soluble factor(s) produced by
cortical epithelial cells are able to regulate apoptosis
and differentiation of thymocytes, and that chol-
inergic signals can modulate this effect.
LYMPHOCYTES EXPRESS CHOLINE-
ACETYL TRANSFERASE AND DOPAMINE-
BETA-HYDROXYLASE, AND SECRETE
ACETYLCHOLINE AND NOREPINEPHRINE
IN CULTURE SUPERNATANTS
Besides the classical immune cytokines, that is, the
interleukins, interferons, and other factors, all mediat-
ing pleiotropic effects on many different tissues,
lymphocytes were found to also produce mediators
previously thought to exclusively belong to the
neuroendocrine system, such as products of the
POMC gene and hormones of the anterior pituitary
gland (Blalock, 1989). We have tested the hypothesis
that immune cells are also able to produce neuro-
transmitters of the autonomous nervous system. Using
the methods of Fonnum (1975) and Nagatsu and
Udenfriend (1972), we could detect the activities of
the key enzymes of acetylcholine and norepinephrine
synthesis, that is, choline-acetyltransferase (CHAT)
and dopamine-/3-hydroxylase, in lymphocyte homo-
genates (Table II). Activities of both enzymes could
be detected in thymic, splenic, and peripheral blood
lymphocytes to a similar extent. Furthermore, very
recently, the ChAT message could be detected by RT-
PCR methods in thymus cells, splenocytes, and PBL
(Rinner et al., to be published).
The concentration of acetylcholine in lymphocytes
and in culture supernatants was measured by a
sensitive RIA (Kawashima et al., 1980). Figure 4(A)
shows that thymocytes, spleen cells, and PBL contain
similar amounts of this neurotransmitter. Stimulation
with PHA significantly increased both the cellular
content and the release of acetylcholine into the
TABLE 2 Choline Acetyltransferase (CHAT) and Dopamine-/3-Hydroxylase (DbH) Activity in Homogenates of Rat Thymic Cells, Spleen
Cells, and Peripheral Blood Lymphocytes (PBL) (pmol mg min-).
ChAT DbH
Thymus cells 34.5 2.8 204.4 24.3
Spleen cells 22.9 _+ 3.3 128.6 _+ 18.1
PBL 13.8 1.6 163.0 13.9
Fibroblasts N.D N.D.
Cultured rat fibroblasts were used as negative control for the enzyme activities. 10 cells were homogenized by sonication, centrifuged,
and the enzyme activity was determined in aliquots of the supernatant using the method of Fonnum (1975) and Nagatsu and Udenfriend
(1972), respectively. Results are means _+ SEM. N 3. N.D.: not detectable.ADRENERGIC/CHOLINERGIC IMMUNOMODULATION 251
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FIGURE 4 Acetylcholine content in (A) lymphatic cells and in (B) the culture medium of the cells from thymus, spleen, ande peripheral
blood. 106 cells were homogenized by sonication. Protein was denaturated by perchloric acid and the neutralized supernatant was used
for the acetylcholine RIA according to Kawashima et al. (1980). Results are means SEM. N 6.
culture medium; see Figure 4(B). Intra- and extra-
cellular catecholamines were determined by the
HPLC technique of Aigner and McManus (1985)
using electrochemical detection. Norepinephrine
could be detected in cellular extracts and culture
supernatants of spleen and PBL (5.3 _+ 0.39 and 1.06
-= 0. 11 pg/106 cells; N 6), but not of thymus cells.
Mitogenic stimulation did not change this pattern (not
shown).
More studies are needed to explore the secretory
mechanism(s) by which lymphocytes release neuro-
transmitters, and to examine the physiological rele-
vance of these phenomena to immunoregulation in
vivo. Nevertheless, the fact that lymphocytes do not
only react to but also are able to produce adrenergic
and cholinergic neurotransmitters suggests close and
mutual relationships to the autonomous nervous
system, and may add to the concept of "the immune
system as mobile brain."
Acknowledgements
The experiments reviewed herein were supported by
the Austrian Science Foundation (projects 7509,
7038, 9925, 10422, and 1130) and by the "Jubi-
liumsfonds der Osterreichischen Nationalbank" (pro-
jects 3556 and 4349).
References
Aigner H. and McManus J. (1985). Bestimmung der Katechola-
mine mit neuem Detektor and Chemikalien-Kit. Labor-Medizin
2: 110-112.
Besedovsky H., Sorkin E., Keller M. and Mtiller J. (1975). Changes
in blood hormone levels during the immune response. Proc. Soc.
Exp. Biol. Med. 150: 466-470.
Blalock J.E. (1989). A molecular basis for bidirectional communi-
cation between the immune and neuroendocrine systems.
Physiol. Rev. 69: 1-27.
Bulloch K. and Moore R.Y. (1981). Innervation of the thymus
gland by brain stem and spinal cord in mouse and rat. Am. J.
Anat. 162:157-166.
Chelmicka-Schorr E. and Arnason B.W. (1990). Nervous system-
immune system interactions. In Immunologic Mechanisms in
Neurologic and Psychiatric Disease, Waksman B.H., Ed. (New
York: Raven Press), pp. 67-90.
Chelmicka-Schorr E., Wollmann R.L., Kwasniewski M.N., Kim
D.H. and Dupont B.L. (1993). The /32-adrenergic agonist
terbutaline suppresses acute passive transfer experimental auto-
immune myasthenia gravis (EAMG). Int. J. Immunopharmacol.
15: 19-24.
Cotman C.W., Brinton R.E., Galaburda A., McEwen B. and
Schneider D.M. (1987). The Neuro-Immune-Endocrine Connec-
tion (New York: Raven Press).
Cunningham E.T. and Souza E.B. (1993). Interleukin-1 receptors in
the brain and endocrine tissues. Immunol. Today 14: 171-176.
De Pelchin A. and Letesson J.J. (1981). Adrenaline influence on the
immune response. I. Accelerating of suppressor effects accord-
ing the time of application. Immunol. Lett. 3: 199-205.
Felsner P., Hofer D., Rinner I., Mangge H., Gruber M., Korsatko
W. and Schauenstein K. (1992). Continuous in vivo treatment
with catecholamines suppresses in vitro reactivity of rat
peripheral blood T-lymphocytes via alpha-mediated mecha-
nisms. J. Neuroimmunol 37: 47-57.
Felsner P., Hofer D., Rinner I., Porta S., Korsatko W. and
Schauenstein K. (1995). Adrenergic suppression of peripheral
blood T cell reactivity in the rat is due to activation of peripheral
c2-receptors. J. Neuroimmunol. 57: 27-34.
Felten D.L., Felten S.Y., Bellinger D.L., Carlson S.L., Ackerman
K.D., Madden K.S., Olschowski J.A. and Livnat S. (1987).
Noradrenergic sympathetic neural interactions with the immune
system: Structure and function. Immunol. Rev. 100: 225-260.
Felten S.Y. and Felten D.L. (1994). Neural-immune interactions.
Prog. Brain Res. 100:157-162.
Fonnum F.A. (1975). Rapid radiochemical method for the deter-
mination of choline acetyltransferase. J. Neurochem. 24:
407-409.
Haas S. and Schauenstein K. (1997). Neuroimmunomodulation via
limbic structures. The neuroanatomy of psychoimmunology.
Prog. Neurobiol. 51: 195-222.252 I. RINNER et al.
Hadden J.W., Hadden E.M. and Middelton E. (1970). Lymphocyte
blast transformation. I. Demonstration of adrenergic receptors in
human peripheral lymphocytes. Cell Immunol. 1: 583-595.
Hickey W.F., Hsu B.L. and Kimura H. (1991). T-Lymphocyte entry
into the central nervous system. J. Neurosci. Res. 28: 254-260.
Hirokawa K., Utsuyama M., Moriizumi E. and Handa S. (1986).
Analysis of the thymic microenvionment by monoclonal anti-
bodies with special reference to the nurse cell. Thymus 112:
449-455.
Kawashima K., Ishikawa H. and Mochizuki M. (1980). Radio-
immunoassay for acetylcholine in the rat brain. J. Pharmacol.
Meth. 3: 115-123.
Liebmann P.M., Hofer D., Felsner P., W61fler A. and Schauenstein
K. (1996). Beta blockade enhances adrenergic immunosuppres-
sion in rats via inhibition of melatonin release. J. Neuroimmunol.
I17: 137-142.
Madden K.S., Felten S.Y., Felten D.L. and Bellinger D.L. (1995).
Sympathetic nervous system-immune system interactions in
young and old Fischer 244 rats. Ann. N.Y. Acad. Sci. 771:
523-534.
Nagatsu T. and Udenfriend S. (1972). Photometric assay of
dopamine-fl-hydroxylase activity in human blood. Clin. Chem.
18: 980-983.
Pearlman D.S. (1971). The effect of adrenergic agents on the
antibody response in vitro. J. Allergy Clin. Immunol. 47:
109-110.
Plaut M. (1987). Lymphocyte hormone receptors. Annu. Rev.
Immunol. 5: 261-269.
Rinner I., Eren R., Skreiner E., Kukulansky T., Kasai M., Hirokawa
K., Globerson A. and Schauenstein K. (1996). Thymocyte-
directed enhancement of apoptosis via soluble factor(s) derived
from a cortical and a medullary thymic epithelial cell line. Cell
Tis. Res. 284: 327-330.
Rinner I., Kukulansky T., Felsner P., Skreiner E., Globerson A.,
Kasai M., Hirokawa K., Korsatko W. and Schauenstein K.
(1994). Cholinergic stimulation modulates apoptosis and
differentiation of murine thymocytes via a nicotinic effect on
thymic epithelium. Biochem. Biophys. Res. Comm. 203:
1057-1062.
Rinner I. and Schauenstein K. (1991). The parasympthetic nervous
system takes part in the immuno-neuroendocrine dialogue. J.
Neuroimmunol. 34:165-172.
Rinner I. and Schauenstein K. (1993). Detection of choline-
acetyltransferase activity in lymphocytes. J. Neurosci. Res. 35:
188-191.
Rinner I., Schauenstein K., Mangge H., Porta S. and Kvetnansky R.
(1992). Opposite effects of mild and severe stress on in vitro
activation of rat peripheral blood lymphocytes. Brain Behav.
Immun. i: 130-140.
Schauenstein K., Fissler R., Dietrich H., Schwarz S., Kr6mer G.
and Wick G. (1987). Disturbed immune-neuroendocrine com-
munication in autoimmune disease. Lack of corticosterone
response to immune signals in Obese Strain chickens with
spontaneous autoimmune thyreoiditis. J. Immunol. 139:
1830-1833.
Smith E.M., Galin F.S., LeBoef R.D., Coppenhaver D.H., Harbour
D.V. and Blalock J.E. (1990). Nucleotide and amino acid
sequence of lymphocyte derived corticotropin: Endotoxin induc-
tion of a truncated peptide. Proc. Natl. Acad. Sci. USA 87:
1057-1060.
Sternberg E., Wilder R.L., Gold P.W. and Chrousos D.P. (1990). A
defect in the central component of the immune system-
hypothalamic-pituitary-adrenal axis feedback loop is associated
with susceptibility to experimental arthritis and other inflamma-
tory diseases. Ann. N.Y. Acad. Sci. 594: 289-292.
Velasco S., Tarlow M., Olson K., Shay J.W., McCracken G.H. and
Nielsen P.D. (1991). Temperature-dependent modulation of
lipopolysaccharide-induced interleukin-1 beta and tumor
necrosis factor-alpha expression in cultured human astroglial
cells by dexamethason and indomethacin. J. Clin. Invest. 87:
1674-1680.